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Abstract We have used ultraviolet laser crosslinking to charac- 
terize the DNA-binding properties of highly purified yeast topo- 
isomerase I! in the absence of ATP. A single 5 ns, 20 mJ pulse 
of 266 nm light produced optimal crosslinking to a short DNA 
duplex, with an efficiency of 0.25%. An equilibrium binding con- 
stant (K~q) of 1.2 + 0.5 x 10 s M -~ was determined from kinetic 
analysis. Topoisomerase II showed highest affinity for super- 
coiled DNA. Limited proteolysis of crosslinked topoisomerase 
II-DNA complexes howed a site of crosslinking to be within a 
29-kDa fragment with Leu-681 at its amino-terminal end. This 
region contains the active Tyr-783 and is homologous to the 
amino-terminal region of the DNA-binding bacterial gyrase 
GyrA subunit, suggesting a conserved DNA-binding mechanism. 
Key words: Topoisomerase II; DNA-binding; Ultraviolet laser 
crosslinking; Saccharomyces cerevisiae 
I. Introduction 
DNA topoisomerase II (topo II) changes DNA topology by 
passing one DNA duplex through another [1]. Topo II plays 
an essential role in chromosome segregation [2M], chromosome 
condensation [3], and the resolution of recombined chromo- 
somes in meiosis [5] and has also been implicated in many other 
processes associated with DNA (reviewed in [6]). 
The topo II catalytic reaction is complex and involves non- 
covalent binding of the enzyme to DNA,  often at crossovers 
[7,8], followed by cleavage of the two DNA strands, which is 
accompanied by covalent attachment of the enzyme to DNA,  
religation of the DNA breaks, and return to the active enzyme 
conformation in a reaction that requires ATP hydrolysis (re- 
viewed in [9]). 
In eukaryotes, topo II is a dimer composed of two identical 
subunits about 1500 amino acids long and contains no obvious 
DNA-binding motifs. The N-terminal 76 amino acid residues 
and C-terminal 260 amino acid residues of fission yeast topo 
II appear to be dispensable for enzymatic activity in vitro, 
implying that DNA-binding domains do not lie in these regions 
[10]. Topo II is conserved among eukaryotes and also has 
significant sequence similarity to bacterial gyrase and phage T4 
topo II subunits [10,11]. Structural and functional features of 
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regions within topo II have been inferred from comparison of 
the predicted amino acid sequence of several eukaryotic topo 
II genes with that of prokaryotic topoisomerases and 
resolvases, whose properties have been studied in more detail. 
The N-terminal half of eukaryotic topo II has similarity to 
GyrB (Fig. 4) and phage gp39 and gp60, which are involved in 
ATP-binding [10]. On the basis of high conservation of certain 
amino acid stretches, Caron and Wang [12] have proposed that 
a region of topo II encompassing the C-terminal part of the 
GyrB-like domain may participate in binding to DNA. The 
central region of topo II has similarly been proposed to partic- 
ipate in binding DNA because of its similarity to the N-terminal 
domain of GyrA (Fig. 4) and phage gp52, which are involved 
in binding DNA and in the catalytic reaction [10]. The C- 
terminal 15% of topo lI has short regions of similarity with 
histone H1 characterized by matching lysine-rich regions, sug- 
gesting that it may also interact with DNA [13]. However, this 
domain has no homology to prokaryotic topoisomerases. 
Here, we report the use of single-pulse ultraviolet (UV) laser 
crosslinking to characterize the interaction of topo I1 with 
DNA and to identify a DNA-binding domain. 
2. Materials and methods 
2.1. Materials 
Plasmid pRYG contains a 54-base pairs (bp) sequence of alternating 
purines and pyrimidines that constitutes a strong topo II cleavage site 
[14]. It was obtained in supercoiled or relaxed form from TopoGEN 
(Columbus, OH). Linear pRYG was obtained by digestion with 
HindIII followed by phenol extraction and ethanol purification. Two 
oligodeoxyribonucleotide duplexes were synthesized by the Nucleic 
Acids Protein Service, University of British Columbia by standard 
methods: 5'-CACACATACATATACATATATATGCATTCATT-3' is 
termed 'RY oligo' and contains part of the alternating purine/pyrim- 
idine sequence from pRYG, and 5'-TGGATTAAAACCTTCTGGT- 
AAGAAAAGAAAAA-3', is termed 'non-RY oligo' and corresponds 
to an adjacent region in pRYG that does not contain any topo II 
cleavage sites [14]. 
S. cerevisiae topo II was overexpressed in yeast from plasmid 
pYepyt2 and purified according to a modification of [15]. Briefly, yeast 
was grown in raffinose to saturation and 2% galactose was added for 
4~6 h. The cells were harvested by centrifugation, washed with cold 
TGEP (0.1 M Tris-HCl, pH 7.6, 10% glycerol, 1 mM EDTA, 1 mM 
EGTA, 1/IM fl-mercaptoethanol, 0.5 mM sodium bisulfite) and lysed 
with glass beads. After centrifugation at800 x g for 5 min, the superna- 
tant was recovered and further centrifuged at 50,000 x g for 15 rain at 
4°C. The pellet was suspended in TGEP containing 0.4 M NaC1 and 
left on ice for 1 h. After centrifugation at100,000 x g for 60 min at 4°C, 
the supernatant was diluted with an equal volume of cold TGEP and 
loaded onto a 2.6 x 12 cm Biorex 70 column. The column was washed 
with 60 ml of TGEP containing 0.2 M NaC1 and topo I1 was eluted with 
a linear gradient of 0.2 to 1.0 M NaC1 in TGEE Active fractions were 
pooled and diluted 4-fold with TGEP before loading onto a Mono-Q 
FPLC column. A linear gradient of 5 to 500 mM NaC1 was applied and 
topo II eluted at about 300 mM NaCI. Purity was evaluated by sodium 
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dodecyl sulfate (SDS) polyacrylamide g l electrophoresis (PAGE) (Fig. 
1A). The purest fraction, labelled 'b' in Fig. 1A, contains a single 
homogenous band and was used for crosslinking experiments. V8 pro- 
tease was purchased from Promega, [y-32p]ATP from N EN, and micro- 
coccal nuclease and polynucleotide kinase from Pharmacia. 
2.2. Binding and UV irradiation 
Standard binding reactions were performed using l 1 nM topo II and 
25 nM RY oligo in 50 mM Tris-HCl (pH 8.0) and 0.5 mM EDTA in 
a total volume of 25/~1. After 3 min incubation at ambient temperature, 
the samples were irradiated with a single pulse of 266 nm light emitted 
from a Nd:YAG laser [16]. The pulse was 5 6 ns long, and its energy 
was 20 mJ. In most experiments, the RY oligo had been end-labelled 
using [y-32p]ATP and polynucleotide kinase, and purified by reversed- 
phase chromatography on Sep-Pak C~8 columns [17]. 
2.3. V8 protease digestion of crosslinked complexes 
Scaled-up reactions contained 11 nM topo II and 25 nM RY oligo 
in 50 mM Tris-acetate (pH 7.5) and 0.5 mM EDTA in a volume of 400 
/11. After 3 min incubation at ambient emperature, 50/~1 aliquots were 
each irradiated with a single 50 mJ pulse. CaC12 was then added to a 
final concentration of 2 mM and the pooled samples were incubated 
with a large excess of micrococcal nuclease (6.25 U/ml, 19 U/mg) for 
30 min at 37°C. The samples were then adjusted to 165 mM potassium 
acetate, 5 mM magnesium acetate, 5 mM fl-mercaptoethanol and 10% 
(w/v) glycerol. Staphylococcus aureus V8 protease was then added at 
1 ¢lg for 30/lg topo II and the samples were incubated at 30°C for up 
to 60 rain. After extraction with phenol and ether (see following sec- 
tion), the samples were dried and solubilized in 50 ,ul of 70 mM Tris- 
HCI (pH 7.6), 10 mM MgCI2, 5 mM DTT containing 25 ¢tCi [y-32P]ATP 
and T4 polynucleotide kinase (8 U) and incubated at 37°C for 45 min. 
The samples were extracted again with phenol and ether, dried and 
prepared for SDS-PAGE. 
2.4. Pheno~ether xtraction of crosslinked complexes 
Sequential extraction with phenol and ether was used to separate 
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Fig. 1. Topo I1 purification and effect of UV irradiation on the lbrmation of crosslinked topo II DNA complexes and on topo 11 and DNA integrity. 
(A) Yeast cells carrying plasmid pYept2 were treated or not with galactose to induce topo II expression and crude extracts were prepared (see section 
2). Topo II was purified by chromatography on BioRex (BioRex input) and Mono-Q columns. Mono-Q fractions a, b and c correspond to the left 
shoulder, the peak, and the right shoulder of the peak of topo I1 activity. Fraction b, which contains a single band at about 160 kDa, was used for 
all crosslinking experiments. The fractions were analysed by SDS-PAGE followed by staining with Coomassie blue. (B) Standard binding reactions 
(see section 2) were incubated for 3 min before irradiation with 0 ( -UV) or 20 mJ (+UV). The crosslinked complexes were separated by SDS-PAGE 
and visualized by autoradiography. The arrow shows the crosslinked complex at about 200 kDa. The migration of protein standards, in kDa, is shown 
to the left. (C) Effect of UV irradiation on the formation of crosslinked complexes (circles), the integrity of topo II (squares), and the integrity of 
RY oligo (triangles). The radioactivity associated with the crosslinked complexes i expressed as percent of the maximal value obtained. The amount 
of intact topo It and RY oligo is expressed as percent of the value of unirradiated samples. 
crosslinked topo II DNA complexes from nucleotides. Samples were 
adjusted to 100/11 with water, an equal volume of phenol was added 
and the samples were vortexed vigorously for 20 s. After 5 min centrif- 
ugation at 12,000 x g, the upper aqueous phase was discarded and the 
phenol phase was extracted up to 4 additional times with water. Two 
volumes of ether were added to the washed phenol phase, and the 
samples were vortexed and centrifuged as above. The upper organic 
phase was discarded and the lower, aqueous phase was extracted twice 
with ether to remove residual phenol. The washed aqueous phase was 
dried by centrifugation u der educed pressure [18]. 
2.5. Gel electrophoresis and analysis" of crosslinked complexes 
Immediately after irradiation, samples were mixed with 1/3 vol of 
4 x SDS loading buffer (200 mM Tris-HCl (pH 6.8), 8% SDS, 0.4% 
bromophenol b ue, 40% glycerol, 1% fl-mercaptoethanol, 4 M urea) 
and boiled for 2 min. The samples were analysed by SDS-PAGE in 8% 
gels with 4% stacking els [17]. After 30 min electrophoresis at200 V, 
the gels were dried onto blotting paper and exposed to Kodak X-AR 
film. Quantitation was obtained by laser scanning densitometry of
bands obtained from autoradiograms exposed without intensifying 
screens, using a Molecular Dynamics Series 300 densitometer, o  with 
a Molecular Dynamics PhosphorImager. In some experiments, proteins 
were silver stained as in [19]. 
3. Results and discussion 
A 
Highly purified S. cerevisiae topo II (Fig. 1A) was incubated 
in the absence of ATP with [32p]RY oligo, consisting of 32 bp 
of alternating purines and pyrimidines, which is efficiently 
cleaved by topo II. An aliquot of the binding reaction was left 
unirradiated or was irradiated with a single 5 ns pulse of 266 
nm light at 20 mJ. SDS loading buffer was added immediately 
and the samples were analysed by SDS-PAGE and autoradi- 
ography. Fig. 1B shows that UV irradiation caused the appear- 
ance of a radiolabelled band at about 200 kDa. This corre- 
sponds roughly to the sum of the masses of a topo II monomer 
(160 kDa) and the 32 bp RY oligo (20.7 kDa), as reported 
previously for other crosslinked protein-DNA complexes [16]. 
We also irradiated binding reactions with a single pulse of 
differing intensity, separated the crosslinked complexes by 
SDS-PAGE, and quantitated them by laser scanning densitom- 
100 
etry of the autoradiographs (Fig. 1C). The appearance of the 
crosslinked complexes was dependent on irradiation and was 
maximal with a 20 mJ pulse. It was also dependent on the 
presence of topo II and of the DNA probe (see later sections). 
We next examined the effect of UV irradiation on the integ- 
rity of topo II and RY oligo. Topo II was irradiated as above, 
the protein was separated by SDS-PAGE, and the amount of 
full-length protein was determined by densitometry after silver- 
staining of the protein. Irradiation doses between 10 and 50 mJ 
resulted in less than 25% topo II degradation (Fig. IC). Simi- 
larly, radioactively labelled RY oligo was irradiated, electro- 
phoresed through a non-denaturing polyacrylamide g l and the 
amount of full-length RY oligo was determined by quantitation 
of autoradiographs. Irradiation doses above 10 mJ caused a 
steady increase in RY oligo degradation (Fig. 1C). Most of the 
subsequent studies described here were performed with one 
pulse of 20 m J, which gave about 0.25% crosslinking efficiency, 
while causing less than 15% degradation of topo II and RY 
oligo. 
It has been shown that crosslinking induced by nanosecond 
or picosecond UV lasers takes place within 1/zs, well below the 
100/zs time scale of microconformational transitions of macro- 
molecules [20 22]. Therefore, the experimental conditions de- 
scribed above are well-suited for the study of binding kinetics 
and of the effect of DNA topology, which is sensitive to UV, 
on topo II binding. [32p]RY oligo (6.25 nM) was incubated with 
excess topo II (8.5 nM) for different imes before UV irradia- 
tion. Crosslinked complex formation was essentially complete 
by 7 s incubation. An association rate constant (ka) of 
3.2 + 1.1 x 10 7 M -l -s lwas determined from 2 experiments as 
described in Cleat and Hay [23]. Dissociation of topo I I -DNA 
complexes was measured by first incubating 32p-labelled RY 
oligo with excess topo II as above. After 30 s incubation, a
16-fold excess (100 nM) of unlabelled RY oligo was added and 
the samples were irradiated at different imes. Dissociation was 
half-maximal at about 7 s. Data from two such experiments 
were used to determine a dissociation rate constant (kd~s~) of 
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Fig. 2. Effect of topo II and DNA concentration  the formation of crosslinked complexes. Standard binding reactions containing a fixed 
concentration f RY oligo (25 nM) and different concentrations of topo II (A) or containing a fixed concentration f topo II (11 nM) and different 
concentrations of RY oligo (B), were assembled and irradiated, and the crosslinked complexes were analysed as in Fig. 1. 
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Fig. 3. Effect of DNA length and topology on the formation of 
crosslinked complexes. Standard binding reactions containing [~:P]RY 
oligo and different concentrations of unlabelled RY oligo (filled 
squares), non-RY oligo (triangles), supercoiled pRYG (filled circles), 
relaxed pRYG (open circles), or linear pRYG (open squares) were 
assembled, irradiated and the crosslinked complexes were analysed as 
in Fig. 1. 
0.26 + 0.04 s -~. This permitted the determination f the equilib- 
rium binding constant (Keq=ka/kdiss) at 1.2 _+ 0.5 × l0 n M -I. 
The dependence of crosslinking efficiency on the composi- 
tion of the binding buffer was also measured. Maximal binding 
was observed in 50 mM Tris-HC1 (pH 8.0), 50 mM NaCl and 
1 mM EDTA, where the NaCl is contributed solely by the topo 
II storage buffer. Raising NaC1 to 100 mM reduced signifi- 
cantly the formation of crosslinked complexes (not shown). All 
binding reactions were performed in the absence of divalent 
cations to prevent DNA cleavage by topo II [24,25]. 
We then determined the effect of topo II concentration and 
of RY oligo concentration on the formation of crosslinked 
complexes. Binding reactions containing a constant concentra- 
tion of RY oligo and increasing topo II concentration were 
irradiated after 3 min incubation (Fig. 2A). No crosslinked 
complexes were observed in the absence oftopo II. The forma- 
tion of crosslinked complexes increased with increasing topo II 
concentration and was half-maximal t 6 nM. Similarly, bind- 
ing reactions containing a constant concentration of topo 11 
and increasing concentration of RY oligo were irradiated. No 
crosslinked complexes were detected in the absence of RY 
oligo. The formation of labelled crosslinked complexes was 
half-maximal t 5 nM and maximal at 20 nM (Fig. 2B). 
We next used the formation of crosslinked topo II [32p]RY 
oligo complexes in competition assays to determine the affinity 
of topo I I for DNA of differing sequence, size, and topological 
state. Topo II (11 nM) was incubated simultaneously with 25 
nM [32p]RY oligo and with increasing concentrations of unla- 
belled RY oligo or non-RY oligo, which contains a sequence 
not cleaved efficiently by topo II. Both oligodeoxyribonucleo- 
tide duplexes competed similarly, with half-maximal competi- 
tion obtained at about 10 #g/ml, or about 12 nM (Fig. 3). This 
indicates that topo II does not bind with higher affinity to 
sequences that are cleaved strongly over sequences that are 
cleaved weakly. 
Plasmid pRYG, from which the 32 bp RY oligo and non-RY 
oligo were derived, was also used in competition assays. The 
plasmid, in its negatively supercoiled form, relaxed by topo I, 
or linearized by restriction enzyme digestion, competed much 
more efficiently with the formation of topo II-32P-labelled RY 
oligo complexes than either RY oligo or non-RY oligo (Fig. 3). 
Half-maximal competition was obtained at 0.15 #g/ml for su- 
percoiled plasmid, and 0.3 #g/ml for both relaxed and linear 
plasmid, or about 0.2 nM and 0.1 nM plasmid, respectively. 
Spitzner et al. [14] have shown that pRYG does not contain 
strong topo II cleavage sites other than those in the RY insert. 
Thus, it is unlikely that the apparent increased binding affinity 
of the plasmid is due to the presence of additional cleavage sites 
within the plasmid. Taken together, our results indicate that 
topo II binds short DNA duplexes with rather high affinity 
(Keq=l × l0 s M -L) irrespective of whether they contain strong 
cleavage sites. Topo II binds much more efficiently to long 
DNA molecules with highest affinity for supercoiled DNA. 
This indicates that DNA topology is a more important determi- 
nant of topo II binding than DNA sequence. Yeast topo II has 
been shown to bind supercoiled DNA more strongly than re- 
laxed DNA by a factor of two to three [26]. Drosophila and 
mammalian topo II also bind supercoiled DNA preferentially 
[7,27]. Roca et al. [8] have shown that binding of yeast opo II 
to DNA crossings is significant, especially in low salt, which is 
the condition we used. This suggests that increased affinity and 
crosslinking efficiency are due to increased ensity of crossings 
in supercoiled DNA. 
Finally, we used this crosslinking technique to identify topo 
II region(s) which interact with DNA. The standard crosslink- 
ing protocol described above results in the formation of com- 
plexes with an electrophoretic mobility corresponding roughly 
to the sum of the molecular mass of the protein and DNA 
components (Fig. 1B). It was modified as follows to minimize 
the effect of the crosslinked DNA on the mobility of the com- 
plexes in SDS gels: topo II was incubated with unlabelled RY 
oligo and irradiated to form crosslinked complexes. DNA was 
then digested extensively with micrococcal nuclease, and the 
complexes were subjected to limited digestion with V8 protease 
as previously described [28]. The proteolysed crosslinked com- 
plexes were then purified, their short crosslinked DNA tag was 
labelled with 32p using polynucleotide kinase, and the com- 
plexes were analysed by SDS-PAGE and autoradiography (see 
section 2). 
Limited digestion of crosslinked topo II-DNA complexes 
with V8 protease gave rise to a well-defined band at 29 kDa and 
a smear below 20 kDa (Fig. 4A). These were not observed when 
samples were not irradiated (Fig. 4A), when topo I! or DNA 
were omitted from the binding reaction, or when samples were 
not digested with V8 (not shown). The labelled 29-kDa band 
was transferred quantitatively to nitrocellulose by electroblot- 
ting, suggesting that it did not consist of incompletely digested 
RY oligo. In addition, it could not have been caused by 
crosslinking of ATP to topo II because polynucleotide kinase 
cannot label mononucleotides and because the labelled band 
required the presence of intact DNA (not shown). The 29-kDa 
crosslinked complex comigrated with a topo II fragment whose 
amino-terminal sequence was determined as X-Ile-Leu-Phe, 
where X indicates an uncertainty in the identification of the 
amino acid residue. This corresponds to cleavage by V8 pro- 
tease at Glu-680, which is followed by Leu-Ile-Leu-Phe, in 
agreement with the results of Lindsley and Wang [28] which 
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Fig. 4. A conserved 29-kDa DNA-binding domain in S. cerevisiae topo II. (A) Topo II was incubated with DNA and irradiated (+UV) or not (-UV). 
The reactions were digested with V8 protease for 60 min and the crosslinked proteolytic fragments were labelled and detected as described in section 
2. The arrow points to the crosslinked 29-kDa fragment. The migration of protein standards, in kDa, is shown to the left. The radiolabelled band 
at about 38 kDa was considered nonspecific because it was observed in the absence of UV irradiation (first lane) or V8 protease digestion (not shown). 
(B) Diagram of the amino acid sequence of S. cerevisiae topo II and regions of similarity to GyrB, GyrA and gp52. Vertical bars represent positions 
in S. cerevisiae topo II which are at least 70% homologous in over 30 type II DNA topoisomerases, a  determined from Fig. 3 of [11]. The 29-kDa 
region marked by the black box represents he region crosslinked to DNA described in this study. E680 is the site cut by V8 protease and Y783 is 
the active site Tyr. (C) Model depicting the interaction of the G DNA segment with topo II and a possible crosslinking site in the open clamp 
conformation of Roca and Wang [26]. In the absence of ATP, the clamp is open and topo II can bind the G segment (G). The X shows crosslinking 
at a site of contact between the G segment in the 29-kDa region postulated to form part of the inside of the clamp. 
also show a prominent V8 protease site at Glu-680. However, 
these authors obtained a 60-kDa proteolytic fragment [28] 
whereas we obtain a 29-kDa fragment. The reason for this 
discrepancy is not known but since the 60-kDa fragment and 
the 29-kDa fragment are both partial digestion products, it is 
likely that the 29-kDa fragment resulted from more extensive 
digestion. The smear below 20 kDa could represent additional 
digestion products of the crosslinked 29-kDa fragment or dis- 
tinct sites of prote in-DNA crosslinking, but this was not stud- 
ied further here. 
Interestingly, Glu-680 is in the junction of the GyrB- and 
GyrA-like domains (Fig. 4B). The 29-kDa fragment contains 
the active Tyr-783 and is homologous to the N-terminal region 
of bacterial GyrA and T4 gp52. The N-terminus of the 29-kDa 
topo II fragment aligns well with that of GyrA and gp52, 
suggesting that it represents a structurally and functionally 
related domain in topo II (Fig. 4B). The 29-kDa topo II frag- 
ment identified in this study is homologous to amino acids 
22 309 of GyrA. Limited digestion of GyrA by trypsin releases 
an N-terminal fragment of 64 kDa that supports DNA super- 
coiling [29], and deletion studies show that the smallest GyrA 
fragment capable of enzyme activity contains amino acids 7- 
523, implying the existence of a DNA-binding domain in this 
region of GyrA. 
According to the ATP-dependent protein clamp model of 
Roca and Wang [26], in the absence of ATE the topo I1 dimer 
forms an open clamp which can bind the G DNA segment, 
whose strands will be cleaved, and the T segment, which will 
be transported through the cleaved G segment. Since our bind- 
ing experiments were performed without ATP or divalent cati- 
ons, crosslinking presumably occured at a site of interaction 
between an uncleaved DNA segment, possibly the G segment, 
and the open topo II clamp. If this is the case, our results would 
predict hat the 29-kDa topo II region that becomes crosslinked 
132 F. Hung et al./FEBS Letters 380 (1996) 127-132 
to DNA contains amino acid residues that project to the inside 
of the protein clamp and serve to bind DNA as depicted in the 
model shown in Fig. 4C. 
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